New implant offers hope for nerve repair after spinal cord injury

A research team at RCSI University of Medicine and Health Sciences has developed a new implant that conveys electrical signals and may have the potential to encourage nerve cell (neuron) repair after spinal cord injury.

FDA approves Astellas’ VYLOY for gastric cancer treatment

VYLOY is used in conjunction with chemotherapy for the treatment of advanced gastric and gastroesophageal junction cancer. Credit: Emily frost/Shutterstock.com. Astellas Pharma has gained approval

October 21, 2024

Cholinesterase inhibitors may slow cognitive decline in dementia with Lewy bodies

Dementia with Lewy bodies is a type of dementia that is similar to both Alzheimer’s disease and Parkinson’s disease but studies on long-term treatments are

August 23, 2024

Tirofiban a Better Option for Ischemic Stroke When Lytics and Thrombectomy Aren’t?

PHOENIX — For acute ischemic stroke patients without thrombolytic or thrombectomy options, tirofiban was better than aspirin alone, the TREND trial showed. In non-cardioembolic stroke,

February 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.